5323002022-04-012022-09-305323002022-09-305323002022-04-012022-09-30RelatedPartyTransactionDomain15323002022-03-31RelatedPartyTransactionDomain15323002022-09-30RelatedPartyTransactionDomain15323002022-04-012022-09-30RelatedPartyTransactionDomain25323002022-03-31RelatedPartyTransactionDomain25323002022-09-30RelatedPartyTransactionDomain25323002022-04-012022-09-30RelatedPartyTransactionDomain35323002022-03-31RelatedPartyTransactionDomain35323002022-09-30RelatedPartyTransactionDomain35323002022-04-012022-09-30RelatedPartyTransactionDomain45323002022-03-31RelatedPartyTransactionDomain45323002022-09-30RelatedPartyTransactionDomain45323002022-04-012022-09-30RelatedPartyTransactionDomain55323002022-03-31RelatedPartyTransactionDomain55323002022-09-30RelatedPartyTransactionDomain55323002022-04-012022-09-30RelatedPartyTransactionDomain65323002022-03-31RelatedPartyTransactionDomain65323002022-09-30RelatedPartyTransactionDomain65323002022-04-012022-09-30RelatedPartyTransactionDomain75323002022-03-31RelatedPartyTransactionDomain75323002022-09-30RelatedPartyTransactionDomain75323002022-04-012022-09-30RelatedPartyTransactionDomain85323002022-03-31RelatedPartyTransactionDomain85323002022-09-30RelatedPartyTransactionDomain85323002022-04-012022-09-30RelatedPartyTransactionDomain95323002022-03-31RelatedPartyTransactionDomain95323002022-09-30RelatedPartyTransactionDomain95323002022-04-012022-09-30RelatedPartyTransactionDomain105323002022-03-31RelatedPartyTransactionDomain105323002022-09-30RelatedPartyTransactionDomain105323002022-04-012022-09-30RelatedPartyTransactionDomain115323002022-03-31RelatedPartyTransactionDomain115323002022-09-30RelatedPartyTransactionDomain115323002022-04-012022-09-30RelatedPartyTransactionDomain125323002022-03-31RelatedPartyTransactionDomain125323002022-09-30RelatedPartyTransactionDomain125323002022-04-012022-09-30RelatedPartyTransactionDomain135323002022-03-31RelatedPartyTransactionDomain135323002022-09-30RelatedPartyTransactionDomain135323002022-04-012022-09-30RelatedPartyTransactionDomain145323002022-03-31RelatedPartyTransactionDomain145323002022-09-30RelatedPartyTransactionDomain145323002022-04-012022-09-30RelatedPartyTransactionDomain155323002022-03-31RelatedPartyTransactionDomain155323002022-09-30RelatedPartyTransactionDomain155323002022-04-012022-09-30RelatedPartyTransactionDomain165323002022-03-31RelatedPartyTransactionDomain165323002022-09-30RelatedPartyTransactionDomain165323002022-04-012022-09-30RelatedPartyTransactionDomain175323002022-03-31RelatedPartyTransactionDomain175323002022-09-30RelatedPartyTransactionDomain175323002022-04-012022-09-30RelatedPartyTransactionDomain185323002022-03-31RelatedPartyTransactionDomain185323002022-09-30RelatedPartyTransactionDomain185323002022-04-012022-09-30RelatedPartyTransactionDomain195323002022-03-31RelatedPartyTransactionDomain195323002022-09-30RelatedPartyTransactionDomain195323002022-04-012022-09-30RelatedPartyTransactionDomain205323002022-03-31RelatedPartyTransactionDomain205323002022-09-30RelatedPartyTransactionDomain205323002022-04-012022-09-30RelatedPartyTransactionDomain215323002022-03-31RelatedPartyTransactionDomain215323002022-09-30RelatedPartyTransactionDomain215323002022-04-012022-09-30RelatedPartyTransactionDomain225323002022-03-31RelatedPartyTransactionDomain225323002022-09-30RelatedPartyTransactionDomain225323002022-04-012022-09-30RelatedPartyTransactionDomain235323002022-03-31RelatedPartyTransactionDomain235323002022-09-30RelatedPartyTransactionDomain235323002022-04-012022-09-30RelatedPartyTransactionDomain245323002022-03-31RelatedPartyTransactionDomain245323002022-09-30RelatedPartyTransactionDomain245323002022-04-012022-09-30RelatedPartyTransactionDomain255323002022-03-31RelatedPartyTransactionDomain255323002022-09-30RelatedPartyTransactionDomain255323002022-04-012022-09-30RelatedPartyTransactionDomain265323002022-03-31RelatedPartyTransactionDomain265323002022-09-30RelatedPartyTransactionDomain265323002022-04-012022-09-30RelatedPartyTransactionDomain275323002022-03-31RelatedPartyTransactionDomain275323002022-09-30RelatedPartyTransactionDomain275323002022-04-012022-09-30RelatedPartyTransactionDomain285323002022-03-31RelatedPartyTransactionDomain285323002022-09-30RelatedPartyTransactionDomain285323002022-04-012022-09-30RelatedPartyTransactionDomain295323002022-03-31RelatedPartyTransactionDomain295323002022-09-30RelatedPartyTransactionDomain295323002022-04-012022-09-30RelatedPartyTransactionDomain305323002022-03-31RelatedPartyTransactionDomain305323002022-09-30RelatedPartyTransactionDomain305323002022-04-012022-09-30RelatedPartyTransactionDomain315323002022-03-31RelatedPartyTransactionDomain315323002022-09-30RelatedPartyTransactionDomain315323002022-04-012022-09-30RelatedPartyTransactionDomain325323002022-03-31RelatedPartyTransactionDomain325323002022-09-30RelatedPartyTransactionDomain325323002022-04-012022-09-30RelatedPartyTransactionDomain335323002022-03-31RelatedPartyTransactionDomain335323002022-09-30RelatedPartyTransactionDomain335323002022-04-012022-09-30RelatedPartyTransactionDomain345323002022-03-31RelatedPartyTransactionDomain345323002022-09-30RelatedPartyTransactionDomain345323002022-04-012022-09-30RelatedPartyTransactionDomain355323002022-03-31RelatedPartyTransactionDomain355323002022-09-30RelatedPartyTransactionDomain355323002022-04-012022-09-30RelatedPartyTransactionDomain365323002022-03-31RelatedPartyTransactionDomain365323002022-09-30RelatedPartyTransactionDomain365323002022-04-012022-09-30RelatedPartyTransactionDomain375323002022-03-31RelatedPartyTransactionDomain375323002022-09-30RelatedPartyTransactionDomain375323002022-04-012022-09-30RelatedPartyTransactionDomain385323002022-03-31RelatedPartyTransactionDomain385323002022-09-30RelatedPartyTransactionDomain385323002022-04-012022-09-30RelatedPartyTransactionDomain395323002022-03-31RelatedPartyTransactionDomain395323002022-09-30RelatedPartyTransactionDomain395323002022-04-012022-09-30RelatedPartyTransactionDomain405323002022-03-31RelatedPartyTransactionDomain405323002022-09-30RelatedPartyTransactionDomain405323002022-04-012022-09-30RelatedPartyTransactionDomain415323002022-03-31RelatedPartyTransactionDomain415323002022-09-30RelatedPartyTransactionDomain415323002022-04-012022-09-30RelatedPartyTransactionDomain425323002022-03-31RelatedPartyTransactionDomain425323002022-09-30RelatedPartyTransactionDomain425323002022-04-012022-09-30RelatedPartyTransactionDomain435323002022-03-31RelatedPartyTransactionDomain435323002022-09-30RelatedPartyTransactionDomain435323002022-04-012022-09-30RelatedPartyTransactionDomain445323002022-03-31RelatedPartyTransactionDomain445323002022-09-30RelatedPartyTransactionDomain445323002022-04-012022-09-30RelatedPartyTransactionDomain455323002022-03-31RelatedPartyTransactionDomain455323002022-09-30RelatedPartyTransactionDomain455323002022-04-012022-09-30RelatedPartyTransactionDomain465323002022-03-31RelatedPartyTransactionDomain465323002022-09-30RelatedPartyTransactionDomain465323002022-04-012022-09-30RelatedPartyTransactionDomain475323002022-03-31RelatedPartyTransactionDomain475323002022-09-30RelatedPartyTransactionDomain475323002022-04-012022-09-30RelatedPartyTransactionDomain485323002022-03-31RelatedPartyTransactionDomain485323002022-09-30RelatedPartyTransactionDomain485323002022-04-012022-09-30RelatedPartyTransactionDomain495323002022-03-31RelatedPartyTransactionDomain495323002022-09-30RelatedPartyTransactionDomain495323002022-04-012022-09-30RelatedPartyTransactionDomain505323002022-03-31RelatedPartyTransactionDomain505323002022-09-30RelatedPartyTransactionDomain505323002022-04-012022-09-30RelatedPartyTransactionDomain515323002022-03-31RelatedPartyTransactionDomain515323002022-09-30RelatedPartyTransactionDomain515323002022-04-012022-09-30RelatedPartyTransactionDomain525323002022-03-31RelatedPartyTransactionDomain525323002022-09-30RelatedPartyTransactionDomain525323002022-04-012022-09-30RelatedPartyTransactionDomain535323002022-03-31RelatedPartyTransactionDomain535323002022-09-30RelatedPartyTransactionDomain535323002022-04-012022-09-30RelatedPartyTransactionDomain545323002022-03-31RelatedPartyTransactionDomain545323002022-09-30RelatedPartyTransactionDomain545323002022-04-012022-09-30RelatedPartyTransactionDomain555323002022-03-31RelatedPartyTransactionDomain555323002022-09-30RelatedPartyTransactionDomain555323002022-04-012022-09-30RelatedPartyTransactionDomain565323002022-03-31RelatedPartyTransactionDomain565323002022-09-30RelatedPartyTransactionDomain565323002022-04-012022-09-30RelatedPartyTransactionDomain575323002022-03-31RelatedPartyTransactionDomain575323002022-09-30RelatedPartyTransactionDomain575323002022-04-012022-09-30RelatedPartyTransactionDomain585323002022-03-31RelatedPartyTransactionDomain585323002022-09-30RelatedPartyTransactionDomain585323002022-04-012022-09-30RelatedPartyTransactionDomain595323002022-03-31RelatedPartyTransactionDomain595323002022-09-30RelatedPartyTransactionDomain595323002022-04-012022-09-30RelatedPartyTransactionDomain605323002022-03-31RelatedPartyTransactionDomain605323002022-09-30RelatedPartyTransactionDomain605323002022-04-012022-09-30RelatedPartyTransactionDomain615323002022-03-31RelatedPartyTransactionDomain615323002022-09-30RelatedPartyTransactionDomain615323002022-04-012022-09-30RelatedPartyTransactionDomain625323002022-03-31RelatedPartyTransactionDomain625323002022-09-30RelatedPartyTransactionDomain625323002022-04-012022-09-30RelatedPartyTransactionDomain635323002022-03-31RelatedPartyTransactionDomain635323002022-09-30RelatedPartyTransactionDomain635323002022-04-012022-09-30RelatedPartyTransactionDomain645323002022-03-31RelatedPartyTransactionDomain645323002022-09-30RelatedPartyTransactionDomain645323002022-04-012022-09-30RelatedPartyTransactionDomain655323002022-03-31RelatedPartyTransactionDomain655323002022-09-30RelatedPartyTransactionDomain655323002022-04-012022-09-30RelatedPartyTransactionDomain665323002022-03-31RelatedPartyTransactionDomain665323002022-09-30RelatedPartyTransactionDomain665323002022-04-012022-09-30RelatedPartyTransactionDomain675323002022-03-31RelatedPartyTransactionDomain675323002022-09-30RelatedPartyTransactionDomain675323002022-04-012022-09-30RelatedPartyTransactionDomain685323002022-03-31RelatedPartyTransactionDomain685323002022-09-30RelatedPartyTransactionDomain685323002022-04-012022-09-30RelatedPartyTransactionDomain695323002022-03-31RelatedPartyTransactionDomain695323002022-09-30RelatedPartyTransactionDomain695323002022-04-012022-09-30RelatedPartyTransactionDomain705323002022-03-31RelatedPartyTransactionDomain705323002022-09-30RelatedPartyTransactionDomain705323002022-04-012022-09-30RelatedPartyTransactionDomain715323002022-03-31RelatedPartyTransactionDomain715323002022-09-30RelatedPartyTransactionDomain715323002022-04-012022-09-30RelatedPartyTransactionDomain725323002022-03-31RelatedPartyTransactionDomain725323002022-09-30RelatedPartyTransactionDomain725323002022-04-012022-09-30RelatedPartyTransactionDomain735323002022-03-31RelatedPartyTransactionDomain735323002022-09-30RelatedPartyTransactionDomain735323002022-04-012022-09-30RelatedPartyTransactionDomain745323002022-03-31RelatedPartyTransactionDomain745323002022-09-30RelatedPartyTransactionDomain745323002022-04-012022-09-30RelatedPartyTransactionDomain755323002022-03-31RelatedPartyTransactionDomain755323002022-09-30RelatedPartyTransactionDomain755323002022-04-012022-09-30RelatedPartyTransactionDomain765323002022-03-31RelatedPartyTransactionDomain765323002022-09-30RelatedPartyTransactionDomain765323002022-04-012022-09-30RelatedPartyTransactionDomain775323002022-03-31RelatedPartyTransactionDomain775323002022-09-30RelatedPartyTransactionDomain775323002022-04-012022-09-30RelatedPartyTransactionDomain785323002022-03-31RelatedPartyTransactionDomain785323002022-09-30RelatedPartyTransactionDomain785323002022-04-012022-09-30RelatedPartyTransactionDomain795323002022-03-31RelatedPartyTransactionDomain795323002022-09-30RelatedPartyTransactionDomain795323002022-04-012022-09-30RelatedPartyTransactionDomain805323002022-03-31RelatedPartyTransactionDomain805323002022-09-30RelatedPartyTransactionDomain805323002022-04-012022-09-30RelatedPartyTransactionDomain815323002022-03-31RelatedPartyTransactionDomain815323002022-09-30RelatedPartyTransactionDomain815323002022-04-012022-09-30RelatedPartyTransactionDomain825323002022-03-31RelatedPartyTransactionDomain825323002022-09-30RelatedPartyTransactionDomain825323002022-04-012022-09-30RelatedPartyTransactionDomain835323002022-03-31RelatedPartyTransactionDomain835323002022-09-30RelatedPartyTransactionDomain835323002022-04-012022-09-30RelatedPartyTransactionDomain845323002022-03-31RelatedPartyTransactionDomain845323002022-09-30RelatedPartyTransactionDomain845323002022-04-012022-09-30RelatedPartyTransactionDomain855323002022-03-31RelatedPartyTransactionDomain855323002022-09-30RelatedPartyTransactionDomain855323002022-04-012022-09-30RelatedPartyTransactionDomain865323002022-03-31RelatedPartyTransactionDomain865323002022-09-30RelatedPartyTransactionDomain865323002022-04-012022-09-30RelatedPartyTransactionDomain875323002022-03-31RelatedPartyTransactionDomain875323002022-09-30RelatedPartyTransactionDomain875323002022-04-012022-09-30RelatedPartyTransactionDomain885323002022-03-31RelatedPartyTransactionDomain885323002022-09-30RelatedPartyTransactionDomain885323002022-04-012022-09-30RelatedPartyTransactionDomain895323002022-03-31RelatedPartyTransactionDomain895323002022-09-30RelatedPartyTransactionDomain895323002022-04-012022-09-30RelatedPartyTransactionDomain905323002022-03-31RelatedPartyTransactionDomain905323002022-09-30RelatedPartyTransactionDomain905323002022-04-012022-09-30RelatedPartyTransactionDomain915323002022-03-31RelatedPartyTransactionDomain915323002022-09-30RelatedPartyTransactionDomain915323002022-04-012022-09-30RelatedPartyTransactionDomain925323002022-03-31RelatedPartyTransactionDomain925323002022-09-30RelatedPartyTransactionDomain925323002022-04-012022-09-30RelatedPartyTransactionDomain935323002022-03-31RelatedPartyTransactionDomain935323002022-09-30RelatedPartyTransactionDomain935323002022-04-012022-09-30RelatedPartyTransactionDomain945323002022-03-31RelatedPartyTransactionDomain945323002022-09-30RelatedPartyTransactionDomain945323002022-04-012022-09-30RelatedPartyTransactionDomain955323002022-03-31RelatedPartyTransactionDomain955323002022-09-30RelatedPartyTransactionDomain955323002022-04-012022-09-30RelatedPartyTransactionDomain965323002022-03-31RelatedPartyTransactionDomain965323002022-09-30RelatedPartyTransactionDomain965323002022-04-012022-09-30RelatedPartyTransactionDomain975323002022-03-31RelatedPartyTransactionDomain975323002022-09-30RelatedPartyTransactionDomain975323002022-04-012022-09-30RelatedPartyTransactionDomain985323002022-03-31RelatedPartyTransactionDomain985323002022-09-30RelatedPartyTransactionDomain985323002022-04-012022-09-30RelatedPartyTransactionDomain995323002022-03-31RelatedPartyTransactionDomain995323002022-09-30RelatedPartyTransactionDomain995323002022-04-012022-09-30RelatedPartyTransactionDomain1005323002022-03-31RelatedPartyTransactionDomain1005323002022-09-30RelatedPartyTransactionDomain1005323002022-04-012022-09-30RelatedPartyTransactionDomain1015323002022-03-31RelatedPartyTransactionDomain1015323002022-09-30RelatedPartyTransactionDomain1015323002022-04-012022-09-30RelatedPartyTransactionDomain1025323002022-03-31RelatedPartyTransactionDomain1025323002022-09-30RelatedPartyTransactionDomain1025323002022-04-012022-09-30RelatedPartyTransactionDomain1035323002022-03-31RelatedPartyTransactionDomain1035323002022-09-30RelatedPartyTransactionDomain1035323002022-04-012022-09-30RelatedPartyTransactionDomain1045323002022-03-31RelatedPartyTransactionDomain1045323002022-09-30RelatedPartyTransactionDomain1045323002022-04-012022-09-30RelatedPartyTransactionDomain1055323002022-03-31RelatedPartyTransactionDomain1055323002022-09-30RelatedPartyTransactionDomain1055323002022-04-012022-09-30RelatedPartyTransactionDomain1065323002022-03-31RelatedPartyTransactionDomain1065323002022-09-30RelatedPartyTransactionDomain1065323002022-04-012022-09-30RelatedPartyTransactionDomain1075323002022-03-31RelatedPartyTransactionDomain1075323002022-09-30RelatedPartyTransactionDomain1075323002022-04-012022-09-30RelatedPartyTransactionDomain1085323002022-03-31RelatedPartyTransactionDomain1085323002022-09-30RelatedPartyTransactionDomain1085323002022-04-012022-09-30RelatedPartyTransactionDomain1095323002022-03-31RelatedPartyTransactionDomain1095323002022-09-30RelatedPartyTransactionDomain1095323002022-04-012022-09-30RelatedPartyTransactionDomain1105323002022-03-31RelatedPartyTransactionDomain1105323002022-09-30RelatedPartyTransactionDomain1105323002022-04-012022-09-30RelatedPartyTransactionDomain1115323002022-03-31RelatedPartyTransactionDomain1115323002022-09-30RelatedPartyTransactionDomain1115323002022-04-012022-09-30RelatedPartyTransactionDomain1125323002022-03-31RelatedPartyTransactionDomain1125323002022-09-30RelatedPartyTransactionDomain1125323002022-04-012022-09-30RelatedPartyTransactionDomain1135323002022-03-31RelatedPartyTransactionDomain1135323002022-09-30RelatedPartyTransactionDomain1135323002022-04-012022-09-30RelatedPartyTransactionDomain1145323002022-03-31RelatedPartyTransactionDomain1145323002022-09-30RelatedPartyTransactionDomain1145323002022-04-012022-09-30RelatedPartyTransactionDomain1155323002022-03-31RelatedPartyTransactionDomain1155323002022-09-30RelatedPartyTransactionDomain1155323002022-04-012022-09-30RelatedPartyTransactionDomain1165323002022-03-31RelatedPartyTransactionDomain1165323002022-09-30RelatedPartyTransactionDomain1165323002022-04-012022-09-30RelatedPartyTransactionDomain1175323002022-03-31RelatedPartyTransactionDomain1175323002022-09-30RelatedPartyTransactionDomain1175323002022-04-012022-09-30RelatedPartyTransactionDomain1185323002022-03-31RelatedPartyTransactionDomain1185323002022-09-30RelatedPartyTransactionDomain1185323002022-04-012022-09-30RelatedPartyTransactionDomain1195323002022-03-31RelatedPartyTransactionDomain1195323002022-09-30RelatedPartyTransactionDomain1195323002022-04-012022-09-30RelatedPartyTransactionDomain1205323002022-03-31RelatedPartyTransactionDomain1205323002022-09-30RelatedPartyTransactionDomain1205323002022-04-012022-09-30RelatedPartyTransactionDomain1215323002022-03-31RelatedPartyTransactionDomain1215323002022-09-30RelatedPartyTransactionDomain1215323002022-04-012022-09-30RelatedPartyTransactionDomain1225323002022-03-31RelatedPartyTransactionDomain1225323002022-09-30RelatedPartyTransactionDomain1225323002022-04-012022-09-30RelatedPartyTransactionDomain1235323002022-03-31RelatedPartyTransactionDomain1235323002022-09-30RelatedPartyTransactionDomain1235323002022-04-012022-09-30RelatedPartyTransactionDomain1245323002022-03-31RelatedPartyTransactionDomain1245323002022-09-30RelatedPartyTransactionDomain1245323002022-04-012022-09-30RelatedPartyTransactionDomain1255323002022-03-31RelatedPartyTransactionDomain1255323002022-09-30RelatedPartyTransactionDomain1255323002022-04-012022-09-30RelatedPartyTransactionDomain1265323002022-03-31RelatedPartyTransactionDomain1265323002022-09-30RelatedPartyTransactionDomain1265323002022-04-012022-09-30RelatedPartyTransactionDomain1275323002022-03-31RelatedPartyTransactionDomain1275323002022-09-30RelatedPartyTransactionDomain1275323002022-04-012022-09-30RelatedPartyTransactionDomain1285323002022-03-31RelatedPartyTransactionDomain1285323002022-09-30RelatedPartyTransactionDomain1285323002022-04-012022-09-30RelatedPartyTransactionDomain1295323002022-03-31RelatedPartyTransactionDomain1295323002022-09-30RelatedPartyTransactionDomain1295323002022-04-012022-09-30RelatedPartyTransactionDomain1305323002022-03-31RelatedPartyTransactionDomain1305323002022-09-30RelatedPartyTransactionDomain1305323002022-04-012022-09-30RelatedPartyTransactionDomain1315323002022-03-31RelatedPartyTransactionDomain1315323002022-09-30RelatedPartyTransactionDomain1315323002022-04-012022-09-30RelatedPartyTransactionDomain1325323002022-03-31RelatedPartyTransactionDomain1325323002022-09-30RelatedPartyTransactionDomain1325323002022-04-012022-09-30RelatedPartyTransactionDomain1335323002022-03-31RelatedPartyTransactionDomain1335323002022-09-30RelatedPartyTransactionDomain1335323002022-04-012022-09-30RelatedPartyTransactionDomain1345323002022-03-31RelatedPartyTransactionDomain1345323002022-09-30RelatedPartyTransactionDomain1345323002022-04-012022-09-30RelatedPartyTransactionDomain1355323002022-03-31RelatedPartyTransactionDomain1355323002022-09-30RelatedPartyTransactionDomain1355323002022-04-012022-09-30RelatedPartyTransactionDomain1365323002022-03-31RelatedPartyTransactionDomain1365323002022-09-30RelatedPartyTransactionDomain1365323002022-04-012022-09-30RelatedPartyTransactionDomain1375323002022-03-31RelatedPartyTransactionDomain1375323002022-09-30RelatedPartyTransactionDomain1375323002022-04-012022-09-30RelatedPartyTransactionDomain1385323002022-03-31RelatedPartyTransactionDomain1385323002022-09-30RelatedPartyTransactionDomain1385323002022-04-012022-09-30RelatedPartyTransactionDomain1395323002022-03-31RelatedPartyTransactionDomain1395323002022-09-30RelatedPartyTransactionDomain1395323002022-04-012022-09-30RelatedPartyTransactionDomain1405323002022-03-31RelatedPartyTransactionDomain1405323002022-09-30RelatedPartyTransactionDomain1405323002022-04-012022-09-30RelatedPartyTransactionDomain1415323002022-03-31RelatedPartyTransactionDomain1415323002022-09-30RelatedPartyTransactionDomain1415323002022-04-012022-09-30RelatedPartyTransactionDomain1425323002022-03-31RelatedPartyTransactionDomain1425323002022-09-30RelatedPartyTransactionDomain1425323002022-04-012022-09-30RelatedPartyTransactionDomain1435323002022-03-31RelatedPartyTransactionDomain1435323002022-09-30RelatedPartyTransactionDomain1435323002022-04-012022-09-30RelatedPartyTransactionDomain1445323002022-03-31RelatedPartyTransactionDomain1445323002022-09-30RelatedPartyTransactionDomain1445323002022-04-012022-09-30RelatedPartyTransactionDomain1455323002022-03-31RelatedPartyTransactionDomain1455323002022-09-30RelatedPartyTransactionDomain1455323002022-04-012022-09-30RelatedPartyTransactionDomain1465323002022-03-31RelatedPartyTransactionDomain1465323002022-09-30RelatedPartyTransactionDomain1465323002022-04-012022-09-30RelatedPartyTransactionDomain1475323002022-03-31RelatedPartyTransactionDomain1475323002022-09-30RelatedPartyTransactionDomain1475323002022-04-012022-09-30RelatedPartyTransactionDomain1485323002022-03-31RelatedPartyTransactionDomain1485323002022-09-30RelatedPartyTransactionDomain1485323002022-04-012022-09-30RelatedPartyTransactionDomain1495323002022-03-31RelatedPartyTransactionDomain1495323002022-09-30RelatedPartyTransactionDomain1495323002022-04-012022-09-30RelatedPartyTransactionDomain1505323002022-03-31RelatedPartyTransactionDomain1505323002022-09-30RelatedPartyTransactionDomain1505323002022-04-012022-09-30RelatedPartyTransactionDomain1515323002022-03-31RelatedPartyTransactionDomain1515323002022-09-30RelatedPartyTransactionDomain1515323002022-04-012022-09-30RelatedPartyTransactionDomain1525323002022-03-31RelatedPartyTransactionDomain1525323002022-09-30RelatedPartyTransactionDomain1525323002022-04-012022-09-30RelatedPartyTransactionDomain1535323002022-03-31RelatedPartyTransactionDomain1535323002022-09-30RelatedPartyTransactionDomain1535323002022-04-012022-09-30RelatedPartyTransactionDomain1545323002022-03-31RelatedPartyTransactionDomain1545323002022-09-30RelatedPartyTransactionDomain1545323002022-04-012022-09-30RelatedPartyTransactionDomain1555323002022-03-31RelatedPartyTransactionDomain1555323002022-09-30RelatedPartyTransactionDomain1555323002022-04-012022-09-30RelatedPartyTransactionDomain1565323002022-03-31RelatedPartyTransactionDomain1565323002022-09-30RelatedPartyTransactionDomain1565323002022-04-012022-09-30RelatedPartyTransactionDomain1575323002022-03-31RelatedPartyTransactionDomain1575323002022-09-30RelatedPartyTransactionDomain1575323002022-04-012022-09-30RelatedPartyTransactionDomain1585323002022-03-31RelatedPartyTransactionDomain1585323002022-09-30RelatedPartyTransactionDomain1585323002022-04-012022-09-30RelatedPartyTransactionDomain1595323002022-03-31RelatedPartyTransactionDomain1595323002022-09-30RelatedPartyTransactionDomain159iso4217:INRxbrli:pureWockhardt Limited532300WOCKPHARMANA2022-04-012023-03-31First half yearly2022-04-012022-09-30CrorestruetrueNANAfalsefalseWockhardt LimitedWockhardt Bio AgSubsidiaryAny other transactionNovation of Outlicensing Rights40714600000Approved3000000000Wockhardt LimitedWockhardt Bio AgSubsidiarySale of goods or services40714600000Approved21920000000Wockhardt LimitedCP Pharmaceuticals LimitedStep down subsidiarySale of goods or services10000000Approved80000000Wockhardt LimitedWockhardt UK LimitedStep down subsidiarySale of goods or services10000000Approved120000000Wockhardt LimitedWockhardt USA LLCStep down subsidiarySale of goods or services10000000Approved40000000Wockhardt LimitedWockhardt Bio AgSubsidiarySale of goods or services40714600000Approved2260000000Wockhardt LimitedPinewood Laboratories LtdStep down subsidiarySale of goods or services10000000Approved250000000Wockhardt LimitedMorton Grove Pharmaceuticals, Inc.Step down subsidiarySale of goods or services20000000Approved460000000Wockhardt LimitedWockhardt Bio (R) LLCStep down subsidiarySale of goods or services10000000Approved10000000Wockhardt LimitedWockhardt Bio AgSubsidiarySale of goods or services40714600000Approved54600000000Wockhardt LimitedWockhardt Bio (R) LLCStep down subsidiarySale of goods or services370000000Approved14760000000Wockhardt LimitedCP Pharmaceuticals LimitedStep down subsidiaryPurchase of fixed assets10000000Approved270000000Wockhardt LimitedWockhardt Infrastructure Development LimitedWholly Owned SubsidiaryPurchase of goods or services0Not applicable7500000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Wockhardt LimitedWockhardt Infrastructure Development LimitedWholly Owned SubsidiaryPurchase of goods or services0Not applicable7610000000<DIV > <DIV></DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Wockhardt LimitedWockhardt Infrastructure Development LimitedWholly Owned SubsidiaryPurchase of goods or services0Not applicable10000000<DIV > <DIV></DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Wockhardt LimitedWockhardt Infrastructure Development LimitedWholly Owned SubsidiaryPurchase of goods or services0Not applicable20000000<DIV > <DIV></DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Wockhardt LimitedMorton Grove Pharmaceuticals, Inc.Step down subsidiaryAny other transactionReimbursement received10000000Approved30000000Wockhardt LimitedWockhardt USA LLCStep down subsidiaryAny other transactionReimbursement received10000000Approved90000000Wockhardt LimitedWockhardt Bio AgSubsidiaryAny other transactionReimbursement received40714600000Approved50000000Wockhardt LimitedCP Pharmaceuticals LimitedStep down subsidiaryAny other transactionReimbursement received10000000Approved140000000Wockhardt LimitedWockhardt UK LimitedStep down subsidiaryAny other transactionReimbursement received10000000Approved190000000Wockhardt LimitedPinewood Laboratories LtdStep down subsidiaryAny other transactionReimbursement received10000000Approved170000000Wockhardt LimitedWockhardt Bio (R) LLCStep down subsidiaryAny other transactionReimbursement received10000000Approved20000000Wockhardt LimitedWockhardt Bio AgSubsidiaryAny other transactionReimbursement paid40714600000Approved1490000000Wockhardt LimitedWockhardt Bio (R) LLCStep down subsidiaryAny other transactionReimbursement paid20000000Approved590000000Wockhardt LimitedWockhardt Bio AGSubsidiaryAny other transactionExport of Goods and Services40714600000Approved37460000000Wockhardt LimitedHumuza ConsultantsPromoter Group EntityAny other transactionAccrued Interest paid3230000000Approved2636000002636000000Wockhardt LimitedKhorakiwala Holdings and Investments Private LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlLoan3230000000Approved7300000025078600002580860000Wockhardt LimitedKhorakiwala Holdings and Investments Private LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlInterest paid3230000000Approved14800000072080000220100000Wockhardt LimitedMerind LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlInterest paid3230000000Approved4180000085250000127020000Wockhardt LimitedAmalthea ConsultantsEnterprises over which Key Managerial Personnel exercise significant influence/controlLoan3230000000Approved7200000000Wockhardt LimitedAmalthea ConsultantsEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionAccrued Interest paid3230000000Approved72200000722000000Wockhardt LimitedAmalthea ConsultantsEnterprises over which Key Managerial Personnel exercise significant influence/controlInterest paid3230000000Approved220000000Wockhardt LimitedThemisto Trustee Company Pvt LtdEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionAccrued Interest paid3230000000Approved36000000360000000Wockhardt LimitedThemisto Trustee Company Pvt LtdEnterprises over which Key Managerial Personnel exercise significant influence/controlInterest paid3230000000Approved1000000Wockhardt LimitedAnanke Trustee Company Pvt LtdEnterprises over which Key Managerial Personnel exercise significant influence/controlLoan3230000000Approved4612000000461200000Wockhardt LimitedAnanke Trustee Company Pvt LtdEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionAccrued Interest paid3230000000Approved35400000354000000Wockhardt LimitedAnanke Trustee Company Pvt LtdEnterprises over which Key Managerial Personnel exercise significant influence/controlInterest paid3230000000Approved160000001630000Wockhardt LimitedCallirhoe Trustee Company Pvt LtdEnterprises over which Key Managerial Personnel exercise significant influence/controlLoan3230000000Approved126000000017700000002426980000Wockhardt LimitedCallirhoe Trustee Company Pvt LtdEnterprises over which Key Managerial Personnel exercise significant influence/controlInterest paid3230000000Approved10050000018790000119240000Wockhardt LimitedCarol Info Services LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlPurchase of goods or services1140000000Approved45410000000Wockhardt LimitedCarol Info Services LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionReimbursement paid20000000Approved610000000Wockhardt LimitedWockhardt Hospitals LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlSale of goods or services10000000Approved20000000Wockhardt LimitedDr. Habil Khorakiwala Education and Health Foundation ( Trust) [Wockhardt Global School]Enterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionReimbursement paid40000000Approved1440000000Wockhardt LimitedPalanpur Holdings and Investments Private LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlPurchase of goods or services20000000Approved460000000Wockhardt LimitedDr. Habil Khorakiwala Education and Health Foundation ( Trust)Enterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionDonation Paid10000000Approved160000000Wockhardt LimitedDr. Habil Khorakiwala Education and Health Foundation ( Trust)Enterprises over which Key Managerial Personnel exercise significant influence/controlSale of goods or services10000000Approved1000000Wockhardt LimitedWockhardt Regenarative Private LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlSale of goods or services10000000Approved1000000Wockhardt LimitedH.F.KhorakiwalaKey managerial personnelRemuneration28000000Approved1200000000Wockhardt LimitedHuzaifa KhorakiwalaKey managerial personnelRemuneration24000000Approved960000000Wockhardt LimitedMurtaza KhorakiwalaKey managerial personnelRemuneration24000000Approved960000000Wockhardt LimitedAkhilesh Krishna GuptaDirectorAny other transactionDirector sitting Fees1000000Approved100000000Wockhardt LimitedAman MehtaDirectorAny other transactionDirector sitting Fees1000000Approved100000000Wockhardt LimitedD S BrarDirectorAny other transactionDirector sitting Fees1000000Approved100000000Wockhardt LimitedEXPORT IMPORT BANK OF INDIA (For Services rendered by Nominee Director - Ms. Rima Marphatia)DirectorAny other transactionDirector sitting Fees300000Approved30000000<DIV > <DIV>1. EXIM Bank had withdrawn the nomination from the Board of the Company. Accordingly, Ms. Rima Marphatia (DIN: 00444343) will cease to be the Nominee Director of the Company with effect from August 03, 2022.</DIV></DIV>Wockhardt LimitedSanjaya BaruDirectorAny other transactionDirector sitting Fees1000000Approved100000000Wockhardt LimitedTasneem MehtaDirectorAny other transactionDirector sitting Fees1000000Approved100000000Wockhardt LimitedVinesh Kumar JairathDirectorAny other transactionDirector sitting Fees1000000Approved100000000Wockhardt LimitedZahabiya H KhorakiwalaDirectorAny other transactionDirector sitting Fees200000Approved20000000Wockhardt LimitedCP Pharmaceuticals LimitedStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable01140000012500000Wockhardt LimitedZ&Z Services GmbHStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable0900000800000Wockhardt LimitedWockhardt USA LLCStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable02430000027600000Wockhardt LimitedWockhardt Bio Pty LimitedStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable0200000200000Wockhardt LimitedWockhardt Bio AGSubsidiaryAny other transactionReceivables (Balances)0Not applicable0978920000010430800000Wockhardt LimitedWockhardt UK LimitedStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable01600000017800000Wockhardt LimitedPinewood Laboratories LimitedStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable024490000050700000Wockhardt LimitedWockhardt Bio (R) LLCStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable09320000075600000Wockhardt LimitedMorton Grove PharmaceuticalsStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable02320000029300000Wockhardt LimitedLaboratoires Negma S.A.SStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable067000006400000Wockhardt LimitedWockhardt Farmaceutica SA DE CVStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable05650000060700000Wockhardt LimitedCP Pharmaceuticals LimitedStep down subsidiaryAny other transactionPayables (Balances)0Not applicable0117300000106100000Wockhardt LimitedWockhardt USA LLCStep down subsidiaryAny other transactionPayables (Balances)0Not applicable07810000083900000Wockhardt LimitedWockhardt Bio AGSubsidiaryAny other transactionPayables (Balances)0Not applicable062431000005930100000Wockhardt LimitedWockhardt UK LimitedStep down subsidiaryAny other transactionPayables (Balances)0Not applicable05090000046000000Wockhardt LimitedPinewood Laboratories LimitedStep down subsidiaryAny other transactionPayables (Balances)0Not applicable023280000043300000Wockhardt LimitedWockhardt Bio (R) LLCStep down subsidiaryAny other transactionPayables (Balances)0Not applicable069200000109700000Wockhardt LimitedMorton Grove PharmaceuticalsStep down subsidiaryAny other transactionPayables (Balances)0Not applicable03000000032300000Wockhardt LimitedWockhardt Infrastructure Development LimitedWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable0642300000719700000Wockhardt LimitedCP Pharmaceuticals LimitedStep down subsidiaryAny other transactionPayables for Capital Goods (Balances)0Not applicable02720000027100000Wockhardt LimitedPinewood Laboratories LimitedStep down subsidiaryAny other transactionPayables for Capital Goods (Balances)0Not applicable0175000008100000Wockhardt LimitedWockhardt Bio AGSubsidiaryAny other transactionPayables for Capital Goods (Balances)0Not applicable017123000001541800000Wockhardt LimitedWockhardt Bio AGSubsidiaryAny other transactionGuarantee Fees Receivable (Balances)0Not applicable0688900000740000000Wockhardt LimitedWockhardt Infrastructure Development LimitedWholly Owned SubsidiaryAny other transactionSecurity Deposit Given (Balances)0Not applicable06850000068500000Wockhardt LimitedMorton Grove PharmaceuticalsStep down subsidiaryAny other transactionOther Receivables (Expense Recovery Balances)0Not applicable04770000052000000Wockhardt LimitedWockhardt Hospitals LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionReceivables (Balances)0Not applicable027000002900000Wockhardt LimitedDr. Habil Khorakiwala Education and Health Foundation ( Trust)Enterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionReceivables (Balances)0Not applicable01500000015000000Wockhardt LimitedWockhardt FoundationEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionReceivables (Balances)0Not applicable0100000100000Wockhardt LimitedWockhardt Regenarative Private LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionReceivables (Balances)0Not applicable01000010000Wockhardt LimitedCarol Info Services LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionPayables (Balances)0Not applicable03940000045300000Wockhardt LimitedWockhardt Hospitals LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionPayables (Balances)0Not applicable063000006300000Wockhardt LimitedPalanpur Holdings and Investments Private LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionPayables (Balances)0Not applicable03650000041500000Wockhardt LimitedMerind LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionPayables (Balances)0Not applicable0100000100000Wockhardt LimitedCarol Info Services LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionSecurity Deposit Given (Balances)0Not applicable0555000000555000000Wockhardt LimitedPalanpur Holdings and Investments Private LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionSecurity Deposit Given (Balances)0Not applicable02750000027500000Wockhardt LimitedWockhardt Regenarative Private LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlAny other transactionOther Receivables (Balances)0Not applicable0300000300000Wockhardt Infrastructure Development LimitedWockhardt Medicines LimitedFellow SubsidiaryInter-corporate deposit0Not applicable700000200000900000Inter-corporate deposit0.051 year (Payable on demand)UnsecuredGeneral Corporate Purposes<DIV > <DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Wockhardt Infrastructure Development LimitedWockhardt Medicines LimitedFellow SubsidiaryInterest received0Not applicable200001000040000<DIV > <DIV></DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Wockhardt Bio AGWockhardt Bio Pty LtdWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable0600000600000<DIV > <DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></DIV></DIV>Wockhardt Bio AGWockhardt Bio Pty LtdWholly Owned SubsidiaryAny other transactionReceivables (Balances)0Not applicable001400000Wockhardt Bio AGWockhardt Bio Pty LtdWholly Owned SubsidiaryAny other transactionAdvance recceived for supplies0Not applicable28700000027800000<DIV ><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-fareast-theme-font: minor-latin; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'></SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>2. </SPAN>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.</SPAN> </P> <DIV></DIV><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'></SPAN></DIV>Wockhardt Bio AGWockhardt Bio Pty LtdWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable0208000003300000Wockhardt Bio AGWockhardt Bio Pty LtdWholly Owned SubsidiarySale of goods or services0Not applicable1680000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Wockhardt Bio AGWockhardt Europe LimitedFellow SubsidiaryAny other transactionLoan Given (Balances)0Not applicable09190000083000000<DIV > <DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>c. For transactions Exchange Rate is considered as on date of transaction executed<o:p></o:p></SPAN></P></DIV> <DIV></DIV></DIV>Wockhardt Bio AGCP Pharmaceuticals LimitedWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable011217000001205000000<DIV > <DIV></DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></DIV>Wockhardt Bio AGCP Pharmaceuticals LimitedWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable08709000002653600000Wockhardt Bio AGCP Pharmaceuticals LimitedWholly Owned SubsidiaryPurchase of goods or services40714600000Approved143630000000Wockhardt Bio AGCP Pharmaceuticals LimitedWholly Owned SubsidiaryAny other transactionReimbursement paid40714600000Approved27830000000Wockhardt Bio AGWockhardt USA LLCStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable054247000005820900000Wockhardt Bio AGWockhardt USA LLCStep down subsidiaryAny other transactionPayables (Balances)0Not applicable073000000120600000Wockhardt Bio AGWockhardt USA LLCStep down subsidiarySale of goods or services40714600000Approved85620000000Wockhardt Bio AGWockhardt UK LimitedWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable01020000010900000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN> <DIV></DIV></DIV>Wockhardt Bio AGWockhardt UK LimitedWholly Owned SubsidiaryAny other transactionReceivables (Balances)0Not applicable001146400000Wockhardt Bio AGWockhardt UK LimitedWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable0733500000125100000Wockhardt Bio AGWockhardt UK LimitedWholly Owned SubsidiarySale of goods or services40714600000Approved235260000000Wockhardt Bio AGWockhardt Bio (R) LLCWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable065000007000000<DIV > <DIV></DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></DIV>Wockhardt Bio AGWockhardt Bio (R) LLCWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable0100000200000Wockhardt Bio AGWockpharma Ireland LimitedWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable079678000008557800000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN> <DIV></DIV></DIV>Wockhardt Bio AGWockpharma Ireland LimitedWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable01620000015300000Wockhardt Bio AGPinewood Laboratories LimitedStep down subsidiaryAny other transactionReceivables (Balances)0Not applicable0133000003300000Wockhardt Bio AGPinewood Laboratories LimitedStep down subsidiaryAny other transactionLoan Taken (Balances)0Not applicable0337000000317900000<DIV > <DIV></DIV> <DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>c. For transactions Exchange Rate is considered as on date of transaction executed<o:p></o:p></SPAN></P></DIV></DIV>Wockhardt Bio AGPinewood Laboratories LimitedStep down subsidiaryAny other transactionAdvance recceived for supplies (balances)0Not applicable02010000021600000<DIV > <DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>c. For transactions Exchange Rate is considered as on date of transaction executed<o:p></o:p></SPAN></P></DIV> <DIV></DIV></DIV>Wockhardt Bio AGPinewood Laboratories LimitedStep down subsidiaryAny other transactionAdvance recceived for supplies0Not applicable2590000010250000071400000<DIV > <DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>c. For transactions Exchange Rate is considered as on date of transaction executed<o:p></o:p></SPAN></P></DIV> <DIV>&nbsp;</DIV> <DIV>2. <SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<o:p></o:p></SPAN></DIV></DIV>Wockhardt Bio AGPinewood Laboratories LimitedStep down subsidiaryAny other transactionPayables (Balances)0Not applicable012900000001206100000Wockhardt Bio AGPinewood Laboratories LimitedStep down subsidiarySale of goods or services0Not applicable3720000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Wockhardt Bio AGPinewood Laboratories LimitedStep down subsidiaryPurchase of goods or services0Not applicable18680000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Wockhardt Bio AGPinewood Laboratories LimitedStep down subsidiaryInterest paid0Not applicable6210000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Wockhardt Bio AGWockhardt Holding Corp.Wholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable024993000002685000000<DIV > <DIV></DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></DIV>Wockhardt Bio AGMorton Grove Pharmaceuticals Inc.Step down subsidiaryAny other transactionReceivables (Balances)0Not applicable043000004600000<DIV > <DIV></DIV> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>1.<SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'> Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></SPAN></P></DIV>Wockhardt Bio AGMorton Grove Pharmaceuticals Inc.Step down subsidiaryAny other transactionPayables (Balances)0Not applicable047902000006617000000Wockhardt Bio AGMorton Grove Pharmaceuticals Inc.Step down subsidiaryPurchase of goods or services40714600000Approved155390000000Wockhardt Bio AGMorton Grove Pharmaceuticals Inc.Step down subsidiaryAny other transactionReimbursement paid40714600000Approved7280000000Wockhardt Bio AGMorton Grove Pharmaceuticals Inc.Step down subsidiaryAny other transactionReimbursement paid40714600000Approved20100000000Wockhardt Bio AGMorton Grove Pharmaceuticals Inc.Step down subsidiaryAny other transactionReimbursement paid40714600000Approved1310000000CP Pharmaceuticals LimitedPinewood Healthcare LimitedFellow SubsidiaryAny other transactionReceivables (Balances)0Not applicable0100000100000CP Pharmaceuticals LimitedWockhardt UK Holdings LimitedFellow SubsidiaryAny other transactionPayables (Balances)0Not applicable0728900000658700000<DIV > <DIV></DIV> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>1.<SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'> Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></SPAN></P></DIV>CP Pharmaceuticals LimitedWockhardt UK Holdings LimitedFellow SubsidiaryAny other transactionPayables (Balances)0Not applicable0270700000244600000<DIV > <DIV></DIV> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>1.<SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'> Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></SPAN></P></DIV>CP Pharmaceuticals LimitedPinewood Laboratories LimitedFellow SubsidiaryAny other transactionPayables (Balances)0Not applicable070200000156600000CP Pharmaceuticals LimitedPinewood Laboratories LimitedFellow SubsidiaryAny other transactionReimbursement received0Not applicable230000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>CP Pharmaceuticals LimitedPinewood Laboratories LimitedFellow SubsidiaryPurchase of goods or services0Not applicable19390000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 8pt"><SPAN style='FONT-SIZE: 10pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-bidi-font-size: 11.0pt'>The value of the related party transaction approved by the audit committee is shown as '0' for transactions by subsidiary(ies) which are not required to be approved by the Audit Committtee of the Listed entity as per Regulation 23 (2) of SEBI LODR, 2015.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>CP Pharmaceuticals LimitedWockhardt UK LimitedFellow SubsidiaryAny other transactionPayables (Balances)0Not applicable001200000Wockhardt UK Holdings LimitedWockhardt Farmaceutica Do Brasil LtdaStep down subsidiaryAny other transactionLoan Given (Balances)0Not applicable01380000012400000<DIV > <DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>c. For transactions Exchange Rate is considered as on date of transaction executed<o:p></o:p></SPAN></P></DIV> <DIV></DIV></DIV>Wockhardt Europe LimitedWockhardt Nigeria LimitedWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable045000004100000<DIV > <DIV></DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></DIV>Wockhardt UK LimitedPinewood Healthcare LimitedFellow SubsidiaryAny other transactionReceivables (Balances)0Not applicable011000001000000<DIV > <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>1.<SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'> Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></SPAN></P></DIV>Wockhardt UK LimitedPinewood Laboratories LimitedFellow SubsidiaryAny other transactionReceivables (Balances)0Not applicable05000000Wockpharma Ireland LimitedPinewood Laboratories LimitedWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable093053000008780200000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN> <DIV></DIV></DIV>Wockpharma Ireland LimitedPinewood Laboratories LimitedWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable015790000001489900000Morton Grove Pharmaceuticals Inc.Wockhardt USA LLCWholly Owned SubsidiaryAny other transactionLoan Taken (Balances)0Not applicable0871700000936400000<DIV > <DIV></DIV> <DIV> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-FAMILY: "Arial",sans-serif; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>c. For transactions Exchange Rate is considered as on date of transaction executed<o:p></o:p></SPAN></P></DIV></DIV>Morton Grove Pharmaceuticals Inc.Wockhardt USA LLCWholly Owned SubsidiaryInterest paid40714600000Approved1820000000Morton Grove Pharmaceuticals Inc.Wockhardt USA LLCWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable0309500000326000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN> <DIV></DIV></DIV>Morton Grove Pharmaceuticals Inc.Wockhardt USA LLCWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable023497000003473400000Morton Grove Pharmaceuticals Inc.Wockhardt USA LLCWholly Owned SubsidiaryAny other transactionPayables (Balances)0Not applicable0218500000273600000Wockhardt UK Holdings LimitedCP Pharmaceuticals LimitedFellow SubsidiaryAny other transactionPayables (Balances)0Not applicable060000005400000Wockhardt LimitedDebashis DeyKey managerial personnelRemuneration5800000Approved210000000Wockhardt LimitedDeepak MadnaniKey managerial personnelRemuneration14200000Approved380000000<DIV > <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 3.75pt"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Mr. Deepak Rajkumar Madnani, Chief Financial Officer of Wockhardt Limited was appointed w.e.f. 7<SUP>th</SUP> June, 2022. </SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 3.75pt"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'></SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Hence, Salary drawn from the date of appointment till 30th September, 2022 is disclosed.<?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Wockhardt Bio AGZ & Z Services GmbH, GermanyWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable000<DIV > <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>1.<SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'> Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>2. </SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>The value as displayed as 0.00 represents amount less than Rs. 50,000.</SPAN> </P> <DIV></DIV></DIV>Wockhardt Bio AGCP Pharma (SCHWEIZ) AGWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable000<DIV > <DIV> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>1.<SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'> Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>2. </SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>The value as displayed as 0.00 represents amount less than Rs. 50,000.</SPAN> </P></DIV></DIV>Wockhardt Bio AGWockhardt France (Holdings) S.A.S.Wholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable000<DIV > <DIV> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>1.<SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'> Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>2. </SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>The value as displayed as 0.00 represents amount less than Rs. 50,000.</SPAN> </P></DIV></DIV>Wockhardt Bio AGPinewood Healthcare LimitedWholly Owned SubsidiaryAny other transactionInvestment (Balances)0Not applicable000<DIV > <DIV> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>1.<SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'> Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate.</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>Please note exchange rate as considered below:</SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'><o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>a. For Opening balance Exchange Rate is considered as on April 01, 2022<o:p></o:p></SPAN></P> <P class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-GB'>b. For Closing balance Exchange Rate is considered as on September 30, 2022<o:p></o:p></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Arial",sans-serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>c. For the value of transactions during the period, Average Exchange Rate is considered.</SPAN></SPAN></P> <P><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>2. </SPAN><SPAN style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; LINE-HEIGHT: 107%; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA'>The value as displayed as 0.00 represents amount less than Rs. 50,000.</SPAN> </P></DIV></DIV>Wockhardt LimitedMerind LimitedEnterprises over which Key Managerial Personnel exercise significant influence/controlLoan0Not applicable0955200000997000000